NO964981L - Factor that reacts with nuclear proteins - Google Patents
Factor that reacts with nuclear proteinsInfo
- Publication number
- NO964981L NO964981L NO964981A NO964981A NO964981L NO 964981 L NO964981 L NO 964981L NO 964981 A NO964981 A NO 964981A NO 964981 A NO964981 A NO 964981A NO 964981 L NO964981 L NO 964981L
- Authority
- NO
- Norway
- Prior art keywords
- reacts
- factor
- oct
- nuclear proteins
- nucleic acid
- Prior art date
Links
- 102000007999 Nuclear Proteins Human genes 0.000 title 1
- 108010089610 Nuclear Proteins Proteins 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 abstract 4
- 108020004707 nucleic acids Proteins 0.000 abstract 4
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 210000004027 cell Anatomy 0.000 abstract 2
- 238000013518 transcription Methods 0.000 abstract 2
- 230000035897 transcription Effects 0.000 abstract 2
- 102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 abstract 1
- 101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 abstract 1
- 102100035591 POU domain, class 2, transcription factor 2 Human genes 0.000 abstract 1
- 101710084411 POU domain, class 2, transcription factor 2 Proteins 0.000 abstract 1
- 239000012190 activator Substances 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
En nukleinsyre kodende for en B-lymfocyt spesifikk aktivator av oktamer sete-mediert j gentranskripsjon som reagerer med POU domenen til Oct-1 og Oct-2 for å aktivere gentranskripsjonen og protein som blir kodet av nukleinsyren er beskrevet. I et ytterligere aspekt av oppfinnelsen er det beskrevet vertsceller inneholdende eller som uttrykker slike nukleinsyrer samt fremgangsmåter for anvendelse av nukleinsyrer og celler transformert dermed.A nucleic acid encoding a B-lymphocyte specific activator of octamer site-mediated gene transcription that reacts with the POU domain of Oct-1 and Oct-2 to activate gene transcription and protein encoded by the nucleic acid is described. In a further aspect of the invention, host cells containing or expressing such nucleic acids are described, as well as methods of using the nucleic acids and cells transformed therewith.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94810299 | 1994-05-24 | ||
| PCT/EP1995/001834 WO1995032284A1 (en) | 1994-05-24 | 1995-05-15 | Factor interacting with nuclear proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO964981L true NO964981L (en) | 1996-11-22 |
| NO964981D0 NO964981D0 (en) | 1996-11-22 |
Family
ID=8218256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO964981A NO964981D0 (en) | 1994-05-24 | 1996-11-22 | Factor that reacts with nuclear proteins |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0763109A1 (en) |
| JP (1) | JPH10500311A (en) |
| AU (1) | AU2734595A (en) |
| CA (1) | CA2188423A1 (en) |
| FI (1) | FI964606L (en) |
| NO (1) | NO964981D0 (en) |
| WO (1) | WO1995032284A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0915976A2 (en) * | 1996-09-27 | 1999-05-19 | Icos Corporation | Method to identify compounds for disrupting protein/protein interactions |
| WO2000078951A1 (en) * | 1999-06-18 | 2000-12-28 | Ariad Gene Therapeutics, Inc. | Chimeric oca-b transcription factors |
| CN1322746A (en) * | 2000-05-09 | 2001-11-21 | 上海博德基因开发有限公司 | New polypeptide human actamer-binding protein 48 and its encoding polynucleotides |
| GB0120441D0 (en) * | 2001-08-22 | 2001-10-17 | Novartis Forschungsstiftung | Model of autoimmune disease and methods for identifying anti autoimmune disease disorders |
| EP1589030A1 (en) * | 2004-04-14 | 2005-10-26 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Bob-1 specific T cells and methods to use |
| CN100340674C (en) * | 2005-04-28 | 2007-10-03 | 中国人民解放军总医院 | Deaf-related gene mutation and its detecting method |
| JP2008072939A (en) * | 2006-09-21 | 2008-04-03 | Fujifilm Corp | Method for detecting and inhibiting multiple myeloma |
-
1995
- 1995-05-15 WO PCT/EP1995/001834 patent/WO1995032284A1/en not_active Application Discontinuation
- 1995-05-15 EP EP95922452A patent/EP0763109A1/en not_active Withdrawn
- 1995-05-15 JP JP7530029A patent/JPH10500311A/en active Pending
- 1995-05-15 CA CA002188423A patent/CA2188423A1/en not_active Abandoned
- 1995-05-15 AU AU27345/95A patent/AU2734595A/en not_active Abandoned
-
1996
- 1996-11-18 FI FI964606A patent/FI964606L/en not_active Application Discontinuation
- 1996-11-22 NO NO964981A patent/NO964981D0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2734595A (en) | 1995-12-18 |
| NO964981D0 (en) | 1996-11-22 |
| FI964606A0 (en) | 1996-11-18 |
| WO1995032284A1 (en) | 1995-11-30 |
| JPH10500311A (en) | 1998-01-13 |
| CA2188423A1 (en) | 1995-11-30 |
| EP0763109A1 (en) | 1997-03-19 |
| FI964606L (en) | 1996-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0010725A (en) | Expression and export of interferon-alpha proteins as fc fusion proteins | |
| ATE294871T1 (en) | NON-TOXIC, NON-TOXIGEN, NON-PATHOGENIC FUSARIUM EXPRESSION SYSTEM AND PROMOTORS AND TERMINATORS FOR USE THEREIN | |
| AU8131294A (en) | Human kunitz-type protease inhibitors | |
| DK127786A (en) | METHOD FOR MANUFACTURING TGF-BETA, DNA AND MRNA CODING TGF-BETA, AND REPLICABLE VECTORS INCLUDING THE DNA AND HOST CELLS CONTAINING THE VECTORS | |
| KR900009981A (en) | Coding genes and gene constructs of aminotransferases, and microorganisms expressing these genes | |
| DK388789D0 (en) | HYBRID DERIVATIVES OF HUMANT PROTEIN D, ITS PRODUCTION AND USE, AND ITS CODING THEREOF, AND THE STRUCTURE AND HOST CELLS CONTAINING THIS DNA | |
| EP0861896A3 (en) | Cell volume regulated human kinase h-sgk | |
| NO964981L (en) | Factor that reacts with nuclear proteins | |
| AU2529095A (en) | Vaccine against mycobacterial infections | |
| DE69504808D1 (en) | CORTICOTROPIN RELEASING RECEPTORS OF FACTOR 2 | |
| ES2106544T3 (en) | DNA CODING THE EP1 RECEPTOR OF PROSTAGLANDIN. | |
| ZA963971B (en) | A method and nucleotide sequence for transforming microorganisms | |
| NO972313L (en) | Peptides capable of binding to the GAP protein SH3 region, nucleotide sequences encoding this, and their production and use | |
| Reisler | On the question of co-operative interaction of myosin heads with F-actin in the presence of ATP | |
| WO1994000572A3 (en) | Gene for ataxia-telangiectasia complementation group d (atdc) | |
| KR850001281A (en) | DNA coding for GRF precursor | |
| NZ334359A (en) | Regulatory gene sequences and transcription factors that silence and enhance the CD95 gene and its use as a medicament | |
| Cheah et al. | Translation of type II procollagen mRNA and hydroxylation of the cell-free product | |
| HUP9801330A2 (en) | Novel pka-binding proteins and uses thereof | |
| DE69031996D1 (en) | HUMAN RECOMBINANT PLACENTAL RIBONUCLEASE INHIBITOR AND METHOD FOR THE PRODUCTION THEREOF | |
| BG103342A (en) | Gax protein domains-containing polypeptides included in the presented transcription and/or interrelated to other proteins corresponding to neucleinic acids, and their application | |
| HUP9902298A2 (en) | Derived tyrosine hydroxylase gene expression system | |
| AU7407696A (en) | Protein which binds ATP and nucleic acid and which possesses putative helicase and ATPase properties | |
| CA2118373A1 (en) | Method to reverse the phenotype of transformed cells by the transcription factor irf-1 | |
| PT663955E (en) | NUCLEIC ACID CODING FOR AN ALPHA-ACETOLACTATE-DERBOBOXYLASE AND ITS APPLICATIONS |